症状性高危颅内狭窄伴循环不良行单纯球囊血管成形术不置入支架
本研究回顾性纳入35例症状性高危颅内狭窄且前向血流不良、药物治疗无效的患者,行单纯球囊血管成形术不置入支架。围手术期平均狭窄由88.4%降至25.3%,30天内主要卒中或死亡1例(2.9%),随访期间严重再狭窄3例(12%)均无症状。作者认为单纯球囊血管成形术是症状性颅内狭窄伴高卒中风险的有效治疗选择。
要点
- 术后平均狭窄由88.4%降至25.3%,末次造影随访平均为34.7%。
- 30天内主要卒中或死亡1例(1/35,2.9%),无术中并发症。
- 末次随访卒中或死亡发生率2.9%,优于SAMMPRIS药物组和支架组结果。
核心结论
- 作者认为,在这组回顾性病例中,单纯球囊血管成形术是症状性颅内狭窄伴高卒中风险的有效治疗选择。
研究设计与样本
- 回顾性研究,纳入2010年1月至2016年12月于首都医科大学宣武医院接受单纯球囊血管成形术不置入支架的症状性高危颅内狭窄伴前向血流不良患者35例,平均年龄64.3岁,平均随访9.7个月。
关键影像表现/征象
- 术前平均狭窄程度为88.4%,术后即刻平均狭窄程度降至25.3%,末次造影随访平均狭窄程度为34.7%。
- 术后前向血流改善,无术中并发症发生。
- 末次随访严重再狭窄3例(3/25,12%),均无相关症状。
诊断标准与关键数值
- 主要终点为30天内主要卒中或死亡,发生1例(1/35,2.9%)。
- 末次随访卒中或死亡发生率为2.9%,作者称优于SAMMPRIS研究药物组和支架置入组的结果。
- 严重再狭窄定义为随访造影所见,发生3例(3/25,12%),均无症状。
临床应用与阅片要点
- 对于症状性高危颅内狭窄伴前向血流不良且药物治疗无效的患者,单纯球囊血管成形术不置入支架可能作为治疗选择。
- 术后需造影随访评估再狭窄,本研究严重再狭窄3例(12%)均无症状。
局限性
- 原文为回顾性系列研究。
- 样本量为35例,平均随访9.7个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Although the Stenting versus Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) study demonstrated a high incidence of perioperative complications for Intracranial Atherosclerotic disease (ICAD) treatments with stent placement, some studies have shown that submaximal angioplasty with an undersized balloon limits the risks of perioperative complications, suggesting that intervention may remain an alternative option for ICAD if perioperative complications are minimized. We sought to evaluate clinical and angiographic outcomes after primary angioplasty without stent placement in patients with symptomatic, high-grade intracranial stenosis and poor antegrade flow who were refractory to medical therapy.
MATERIALS AND METHODS: All cases with high-grade, symptomatic intracranial stenosis and poor antegrade flow treated with intracranial angioplasty without stent placement at Xuanwu Hospital, Capital Medical University, from January 2010 to December 2016, were retrospectively reviewed. The main outcomes included the changes in antegrade flow and residual stenosis and any stroke or death within 1 month. We also evaluated functional outcomes, stroke, and restenosis in patients on follow-up.
RESULTS: Thirty-five patients (mean age, 64.3 years) were included, and the mean follow-up time was 9.7 months. The average preprocedural stenosis was 88.4%. The immediate, average postprocedure stenosis rate was 25.3%, and the average postprocedural stenosis rate at last angiographic follow-up was 34.7%. The primary end point of major stroke or death at 30 days was observed in 1 patient (1/35, 2.9%), and no patient had intraprocedural complications. The incidence of stroke or death at the last follow-up was 2.9%, which was superior to the results of the medical and stent-placement arms of the SAMMPRIS study. Severe restenosis was observed in 3 (3/25, 12%) patients but without any symptoms.
CONCLUSIONS: In this retrospective series, primary balloon angioplasty was an effective treatment option for symptomatic intracranial stenosis with a high risk of stroke.
引用
- Wang Y, Ma Y, Gao P, et al. Primary Angioplasty without Stenting for Symptomatic, High-Grade Intracranial Stenosis with Poor Circulation. AJNR Am J Neuroradiol. 2018. PMID: 29976834. doi:10.3174/ajnr.A5708
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。